Canada markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.43-0.08 (-0.46%)
At close: 04:00PM EDT
17.43 0.00 (0.00%)
After hours: 04:57PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-132,348
-153,162
111,214
-65,570
-51,799
-
Depreciation & amortization
314
310
93
53
62
-
Stock based compensation
31,406
30,438
27,957
24,375
14,910
-
Change in working capital
-7,423
-339
11,176
-3,541
6,851
-
Accounts Payable
1,677
-167
-509
-4,835
5,581
-
Other working capital
-121,574
-134,483
-127,797
-43,433
-29,782
-
Other non-cash items
-
131
374
67
7,630
-
Net cash provided by operating activites
-121,525
-134,275
-126,664
-43,433
-29,772
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-208
-1,133
-
-10
-20
Purchases of investments
-415,613
-373,383
-377,916
-525,813
-69,763
-
Sales/Maturities of investments
449,240
409,397
352,933
192,038
62,903
-
Net cash used for investing activites
33,578
35,806
248,975
-333,775
-5,420
-
Cash flows from financing activities
Debt repayment
-
0
-2,200
0
-
-
Common stock issued
-
38,388
0
267,268
145,450
-
Common stock repurchased
-
-
-
-
-213
-378
Other financing activites
-
-
-32,128
-1,765
-5,366
1,843
Net cash used privided by (used for) financing activities
40,047
40,751
-25,933
268,784
140,140
-
Net change in cash
-47,900
-57,718
96,378
-108,424
104,948
-
Cash at beginning of period
122,128
156,152
59,774
168,198
63,250
-
Cash at end of period
74,228
98,434
156,152
59,774
168,198
-
Free Cash Flow
Operating Cash Flow
-121,525
-134,275
-126,664
-43,433
-29,772
-
Capital Expenditure
-
-208
-1,133
-
-10
-20
Free Cash Flow
-121,574
-134,483
-127,797
-43,433
-29,782
-